STAT3 and lung carcinoma: Constitutive PD-L1 expression, known as innate immune resistance, is created by the deletion or silencing of PTEN found in glioblastoma [32] or by a signal transducer and activator of transcription 3 (STAT 3) signalling found in lymphoma and occasionally in lung cancer [33].